Zelixir Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $14.5M

  • Investors
  • 10

Zelixir General Information

Description

Developer of biobased manufacturing technology designed for synthetic biology. The company utilizes artificial intelligence and synthetic biology to produce natural vanillin, biobased raw materials, protein modeling tools, enzyme reaction extractors, functional food ingredients, and beauty product ingredients, providing food and beverage markets with sustainable alternatives to traditional chemical synthesis.

Contact Information

Website
www.zelixir.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4th Floor, Youyue International, Number 298 Xiangke Road, Zhangjiang High-Tech Park
  • Pudong New Area
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 4th Floor, Youyue International, Number 298 Xiangke Road, Zhangjiang High-Tech Park
  • Pudong New Area
  • Shanghai, 201203
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zelixir Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 27-Apr-2023 $14.5M Completed Generating Revenue
2. Early Stage VC 01-Aug-2021 Completed Generating Revenue
1. Seed Round 01-Jul-2021 Completed Startup
To view Zelixir’s complete valuation and funding history, request access »

Zelixir Patents

Zelixir Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025241548-A1 4-vinylguaiacol oxygenase mutant for synthesizing vanillin, and engineered bacterium thereof Pending 23-May-2024
WO-2023131206-A1 Method and apparatus for evaluating bonding strength of complex, and computer device Inactive 04-Jan-2022
WO-2023116816-A1 Protein sequence alignment method and apparatus, and server and storage medium Inactive 23-Dec-2021

Zelixir Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ally Bridge Group Growth/Expansion Minority
Heda Ventures Venture Capital Minority
HM Capital Venture Capital Minority
Hongfeng Capital Growth/Expansion Minority
Lake Bleu Capital Hedge Fund Minority
You’re viewing 5 of 10 investors. Get the full list »

Zelixir FAQs

  • When was Zelixir founded?

    Zelixir was founded in 2021.

  • Where is Zelixir headquartered?

    Zelixir is headquartered in Shanghai, China.

  • What industry is Zelixir in?

    Zelixir’s primary industry is Biotechnology.

  • Is Zelixir a private or public company?

    Zelixir is a Private company.

  • What is Zelixir’s current revenue?

    The current revenue for Zelixir is .

  • How much funding has Zelixir raised over time?

    Zelixir has raised $14.5M.

  • Who are Zelixir’s investors?

    Ally Bridge Group, Heda Ventures, HM Capital, Hongfeng Capital, and Lake Bleu Capital are 5 of 10 investors who have invested in Zelixir.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process